| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Pres, Prod Dev &Med Aff &CMO | Pres Prod Dev &Med Aff &CMO
1 company
Schwab Gisela is a Pres, Prod Dev &Med Aff &CMO at EXELIXIS, INC.. Recent SEC Form 4 filings include 0 buys and 11 sells.
Estimated insider holdings value: $35.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 3, 2019 | EXEL Exelixis, Inc. | Pres, Prod Dev &Med Aff &CMO | Sale+OE | 50,000 | $16.22 | $811,000.00 | -13.8% | |
| Nov 4, 2019 | EXEL Exelixis, Inc. | Pres, Prod Dev &Med Aff &CMO | Sale+OE | 50,000 | $15.99 | $799,500.00 | -13.4% | |
| Oct 1, 2019 | EXEL Exelixis, Inc. | Pres, Prod Dev &Med Aff &CMO | Sale+OE | 30,000 | $17.87 | $536,100.00 | -8.5% | |
| Apr 3, 2019 | EXEL Exelixis, Inc. | Pres, Prod Dev &Med Aff &CMO | Sale+OE | 63,109 | $25.00 | $1,577,725.00 | -16.6% | |
| Mar 25, 2019 | EXEL Exelixis, Inc. | Pres, Prod Dev &Med Aff &CMO | Sale+OE | 100,000 | $23.14 | $2,314,000.00 | -24.0% | |
| Feb 15, 2019 | EXEL Exelixis, Inc. | Pres, Prod Dev &Med Aff &CMO | Sale+OE | 123,000 | $21.76 | $2,676,600.00 | -16.3% | |
| Dec 3, 2018 | EXEL Exelixis, Inc. | Pres, Prod Dev &Med Aff &CMO | Sale+OE | 13,499 | $21.02 | $283,748.98 | -4.1% | |
| Nov 1, 2018 | EXEL Exelixis, Inc. | Pres, Prod Dev &Med Aff &CMO | Sale+OE | 12,000 | $14.16 | $169,920.00 | -3.5% | |
| Oct 1, 2018 | EXEL Exelixis, Inc. | Pres, Prod Dev &Med Aff &CMO | Sale+OE | 12,000 | $17.77 | $213,240.00 | -3.5% | |
| Sep 4, 2018 | EXEL Exelixis, Inc. | Pres Prod Dev &Med Aff &CMO | Sale+OE | 22,500 | $18.53 | $416,925.00 | -6.4% |